Modufolin (arfolitixorin): Clinical Trials

2 trials of Modufolin (arfolitixorin), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Modufolin (arfolitixorin): new trials by email Literature Review of Modufolin (arfolitixorin) trials Research Report on Modufolin (arfolitixorin)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers
Modufolin (arfolitixorin) - Phase I Study in Healthy Volunteers to Evaluate ECG Effect
Phase 1CompletedIsofol Medical AB332017-07-042020-09-25
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
Modufolin (arfolitixorin), Fluorouracil, Oxaliplatin - Colorectal Neoplasm
Phase 1 / Phase 2CompletedIsofol Medical AB1052014-09-012020-09-09

Conditions studied

Colorectal Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Neoplasms (1)

Sponsors

Isofol Medical AB (2)

Countries

Sweden (2)  ·  Denmark (1)  ·  Greece (1)  ·  Norway (1)

Results publications

PMID 33099678, PMID 36183444

NIH funding

2014 (1)